Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Autologous alpha-DC1/TBVA vaccine |
Trade Name | |
Synonyms | |
Drug Descriptions |
Autologous alpha-DC1/TBVA vaccine is comprised of patient-derived dendritic cells loaded with tumor blood vessel antigen (TBVA)-derived peptides, which may lead to increased antitumor immune response (PMID: 34782430). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Autologous alpha-DC1/TBVA vaccine | Autologous alpha-DC1/TBVA vaccine | 0 | 0 |
Autologous alpha-DC1/TBVA vaccine + Cabozantinib | Autologous alpha-DC1/TBVA vaccine Cabozantinib | 0 | 1 |
Autologous alpha-DC1/TBVA vaccine + Dasatinib | Autologous alpha-DC1/TBVA vaccine Dasatinib | 0 | 0 |